- Home /
- Live Rates /
- CRL

CRL
Last Updated: Jun 24, 2026 03:06:34 PM (GMT)
CRL: The current market price is 30.78, which indicates a change from previous prices is not available.
Support and Resistance Levels The support levels are 30.78, 30.78, and 30.78, while the resistance levels are also 30.78, 30.78, and 30.78. The pivot point is at 30.78.
Indicators Current RSI is 57.53, which is steady from previous values showing a bullish trend. ATR is at 0.10685, indicating low market volatility. The Parabolic SAR at 31.72365 indicates potential upward momentum. MACD shows a positive histogram at 0.03801 signaling bullish momentum.
Market Sentiment The price is at the pivot point of 30.78, supported by RSI and MACD trends indicating a bullish scenario overall.
CRL Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (crl) Charles River Laboratories International, Inc.
Company Background
Charles River Laboratories International, Inc. (NYSE: CRL) is a leading global provider of research models and services that cater to the biopharmaceutical and biotechnology sectors. Founded in 1947 and headquartered in Wilmington, Massachusetts, Charles River offers a comprehensive suite of services, including preclinical and clinical laboratory services, animal models, and various research solutions. The company's mission is to improve the quality and efficiency of drug discovery and development, enabling customers to bring life-saving therapies to market faster.
Market Position
With over 75 years of experience, Charles River holds a commanding position in the life sciences industry. The company operates in more than 20 countries and serves a diverse clientele, ranging from emerging biotech firms to large pharmaceutical companies. Charles River is recognized for its commitment to innovation and high-quality standards, providing critical services in areas such as toxicology, pharmacology, and genetic testing. This robust market presence not only enhances its reputation but also establishes the company as a trusted partner in the drug development process.
Key Financial Highlights
As of 2023, Charles River Laboratories reported impressive financial results, demonstrating steady growth and profitability. The company has consistently achieved double-digit revenue growth, driven by increased demand for its services in preclinical and clinical development. Recent earnings reports reflect a strong performance with revenues exceeding $3 billion, showcasing a resilient business model adaptable to market dynamics. Additionally, Charles River's strategic acquisitions and investments in cutting-edge technologies have solidified its position as a frontrunner in the industry. The company continues to focus on expanding its service offerings, enhancing operational efficiencies, and investing in innovation to meet the evolving needs of its clients.
Industry Trends and Future Outlook
The biopharmaceutical industry continues to evolve, with increasing investments in research and development, particularly in personalized medicine and biologics. Charles River is well-positioned to capitalize on these trends, offering tailored solutions that support its clients throughout the drug development process. With a strong pipeline of services and a commitment to sustainability and ethical practices, Charles River Laboratories International, Inc. is poised for long-term success and continued leadership in the life sciences sector.
How to Buy or Trade Charles River Laboratories International, Inc. Stock (CRL) with AvaTrade
Trading or investing in Charles River Laboratories International, Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol CRL, which represents Charles River Laboratories International, Inc.. Before placing a trade, review the live Charles River Laboratories International, Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Charles River Laboratories International, Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Charles River Laboratories International, Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Indicator Alert
Warning: Several indicator values are missing for this timeframe. Please choose another timeframe to continue.
Sidebar rates
- <% signal.pair %>
<% signal.analyst %>
